2016-06-20 | Reiterated Rating | Wedbush | Neutral | $4.00 |
2016-05-16 | Reiterated Rating | Gabelli | Neutral | |
2016-05-14 | Reiterated Rating | Wedbush | Buy | |
2016-05-14 | Reiterated Rating | Needham & Company LLC | Hold | |
2016-05-13 | Downgrade | Gabelli | Buy to Hold | $7.00 |
2016-05-13 | Lower Price Target | Wedbush | Outperform | $8.00 to $4.00 |
2016-05-05 | Reiterated Rating | Wedbush | Neutral | $8.00 to $11.00 |
2016-04-11 | Initiated Coverage | BMO Capital Markets | Market Perform | $8.00 |
2016-02-24 | Reiterated Rating | Wedbush | Neutral | $11.00 |
2015-11-19 | Upgrade | SunTrust | Neutral to Buy | $12.00 to $21.00 |
2015-11-19 | Upgrade | SunTrust Banks Inc. | Neutral to Buy | $12.00 to $21.00 |
2015-11-18 | Reiterated Rating | Needham & Company LLC | Hold | |
2015-11-17 | Reiterated Rating | Wedbush | Neutral | $11.00 |
2015-11-02 | Reiterated Rating | Needham & Company LLC | Hold | |
2015-09-09 | Downgrade | SunTrust | Buy to Neutral | $54.00 to $12.00 |
2015-09-09 | Lower Price Target | Guggenheim | Buy | $60.00 to $20.00 |
2015-09-09 | Downgrade | Wedbush | Outperform to Neutral | $11.00 |
2015-09-09 | Downgrade | Robert W. Baird | Outperform to Neutral | $41.00 to $10.00 |
2015-09-09 | Downgrade | Needham & Company LLC | Buy to Hold | |
2015-09-09 | Downgrade | Cantor Fitzgerald | Buy to Hold | $50.00 to $11.00 |
2015-09-09 | Downgrade | Nomura | Buy to Neutral | $54.00 to $10.00 |
2015-09-09 | Downgrade | Stifel Nicolaus | Buy to Hold | $57.00 |
2015-09-09 | Downgrade | Brean Capital | Buy to Hold | |
2015-09-09 | Downgrade | JMP Securities | Outperform to Market Perform | |
2015-09-09 | Downgrade | Nomura Holdings Inc. | Buy to Neutral | $54.00 to $10.00 |
2015-08-07 | Reiterated Rating | Cantor Fitzgerald | Buy | $50.00 |
2015-08-06 | Reiterated Rating | Stifel Nicolaus | Buy | $54.00 to $57.00 |
2015-08-06 | Boost Price Target | Needham & Company LLC | Buy | $46.00 to $56.00 |
2015-08-06 | Boost Price Target | Brean Capital | Buy | $50.00 to $51.00 |
2015-07-16 | Boost Price Target | Guggenheim | Buy | $45.00 to $60.00 |
2015-06-26 | Boost Price Target | Cantor Fitzgerald | Buy | $46.00 to $50.00 |
2015-06-18 | Reiterated Rating | SunTrust | Buy | $48.00 |
2015-05-07 | Reiterated Rating | Needham & Company LLC | Buy | $46.00 |
2015-05-06 | Reiterated Rating | Cantor Fitzgerald | Buy | $46.00 |
2015-04-27 | Set Price Target | Brean Capital | Buy | $50.00 |
2015-03-23 | Initiated Coverage | SunTrust | Buy | $48.00 |
2015-03-23 | Initiated Coverage | Nomura | Buy | $54.00 |
2015-03-06 | Set Price Target | Brean Capital | Buy | $50.00 |
2015-03-06 | Boost Price Target | Cantor Fitzgerald | Buy | $40.00 to $46.00 |
2014-12-18 | Reiterated Rating | Robert W. Baird | Buy | $41.00 |
2014-12-18 | Reiterated Rating | Wedbush | Buy | $51.00 |
2014-12-18 | Boost Price Target | Needham & Company LLC | Buy | $28.00 to $46.00 |
2014-12-18 | Boost Price Target | Cantor Fitzgerald | BUY | $26.00 to $40.00 |
2014-12-18 | Boost Price Target | Stifel Nicolaus | Buy | $28.00 to $54.00 |
2014-12-18 | Boost Price Target | Guggenheim | $45.00 | |
2014-12-18 | Boost Price Target | Brean Capital | Buy | $23.00 to $50.00 |
2014-11-04 | Initiated Coverage | Wedbush | Outperform | $31.00 |
2014-10-07 | Reiterated | Needham | Buy | $17 to $28 |
2014-10-07 | Boost Price Target | Needham & Company LLC | Buy | $17.00 to $28.00 |
2014-10-07 | Boost Price Target | Stifel Nicolaus | Buy | $21.00 to $28.00 |
2014-09-30 | Boost Price Target | JMP Securities | Outperform | $20.00 to $32.00 |
2014-09-08 | Initiated Coverage | Cantor Fitzgerald | Buy | $22.00 |
2014-09-03 | Boost Price Target | JMP Securities | Outperform | $16.00 to $20.00 |
2014-07-08 | Initiated Coverage | Brean Capital | Buy | $23.00 |
2014-06-20 | Initiated Coverage | Gabelli | Buy | |
2014-06-17 | Initiated | Robert W. Baird | Outperform | $21 |
2014-06-16 | Initiated Coverage | Robert W. Baird | Outperform | $21.00 |
2014-06-02 | Upgrade | WBB Securities | Speculative Buy to Buy | $13.50 to $16.00 |
2014-04-04 | Initiated | Brean Capital | Buy | $23 |
2014-04-03 | Initiated Coverage | Brean Capital | Buy | $23.00 |
2014-03-06 | Boost Price Target | Needham & Company LLC | Buy | $15.00 to $17.00 |
2014-01-10 | Boost Price Target | Barclays | Overweight | $16.00 to $17.00 |
2013-11-13 | Initiated Coverage | Guggenheim | Buy | $25.00 |
2013-10-02 | Boost Price Target | Ladenburg Thalmann | Buy | $13.00 to $15.00 |
2013-10-01 | Boost Price Target | JMP Securities | Market Outperform | $12.00 to $16.00 |
2013-10-01 | Reiterated Rating | Needham & Company LLC | Buy | $12.00 to $15.00 |
2013-09-30 | Initiated Coverage | WBB Securities | Speculative Buy |
2016-06-20 | Reiterated Rating | Wedbush | Neutral | $4.00 |
2016-05-16 | Reiterated Rating | Gabelli | Neutral | |
2016-05-14 | Reiterated Rating | Wedbush | Buy | |
2016-05-14 | Reiterated Rating | Needham & Company LLC | Hold | |
2016-05-13 | Downgrade | Gabelli | Buy to Hold | $7.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In TTPH 13 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
Numeric Investors LLC | 1.99M |
BlackRock Fund Advisors | 1.22M |
BlackRock Institutional Trust Company, N.A. | 0.90M |
BlackRock Investment Management, LLC | 0.15M |
TEACHERS ADVISORS INC | 0.12M |
TIAA CREF INVESTMENT MANAGEMENT LLC | 97364 |
RUSSELL FRANK CO/ | 67976 |
Riverloft Capital Management L.P. | 25000 |
KCG Holdings, Inc. | 20585 |
MANAGED ACCOUNT ADVISORS LLC | 18924 |
BLACKROCK ADVISORS LLC | 18906 |
LADENBURG THALMANN FINANCIAL SERVICES INC | 150 |
HUNTINGTON NATIONAL BANK | 1 |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
EXCEL MEDICAL FUND LP | 5.66% (1468505) | TTPH / |
Flagship Ventures Fund 2004 L P | 4.49% (1165786) | BIND / CNCE / TTOO / TTPH / |
MEDIPHASE VENTURE PARTNERS II LP | 2.08% (540592) | TTPH / |
Macdonald Guy President and Chief Executive | 0.50% (129006) | SCYX / TTPH / |
Lubner David Charles SVP and CFO | 0.27% (69270) | TTPH / |
Trias Joaquim | 0.20% (52569) | TTPH / |
CMEA VENTURES VI LP | 0.18% (47992) | IMI / TTPH / |
GAGE L PATRICK | 0.15% (38880) | CYTK / PDLI / TTPH / |
Gullans Steven R. Ph.D. | 0.10% (25000) | TTPH / |
Sutcliffe Joyce A. Senior Vice President, Biology | 0.07% (17242) | TTPH / |
Horn Patrick Taylor Chief Medical Officer | 0.04% (10000) | TTPH / |
Xiao Xiao-Yi | 0.03% (9033) | TTPH / |
Dumas Jacques Chief ScientificOfficer | 0.03% (8750) | IDIX / TTPH / |
Freund John Gordon | 0.02% (6012) | CNCE / MAKO / PRTO / TTPH / XNPT / |
Skyline Venture Partners Qualified Purchaser Fund IV L P | 0.02% (4493) | ABIO / ACRX / CNCE / TTPH / |
Stahl Maria D SVP and General Counsel | 0.01% (2500) | IDIX / TTPH / |